长效胰岛素联合口服降糖药治疗2型糖尿病的疗效研究

Study on the Effect of Long Acting Insulin Combined with Oral Hypoglycemic Agents for Type 2 Diabetes

目的就长效胰岛素联合口服降糖药使用于2型糖尿病的临床疗效展开分析探究。方法选取2014年1月—2015年1月时间段该院接收的100例2型糖尿病患者,将他们划分成为研究组与对照组,各50例,对照组单纯采取降糖药治疗,研究组基于对照组采取长效胰岛素联合治疗,就两个组别患者临床治疗效果进行比较分析。结果研究组FBG(4.9±0.5)mmol/L、2h PBG(7.9±2.1)mmol/L及Hb A1c(5.9±1.0)%相较于对照组(8.1±0.9)mmol/L、(12.8±2.7)mmol/L及(8.7±1.6)%更低,数据对比差异有统计学意义(P<0.05);研究组血糖控制率94.0%相较于对照组76.0%明显更高,数据对比差异有统计学意义(P<0.05)。结论长效胰岛素联合口服降糖药使用于2型糖尿病患者临床疗效理想,可明显促进患者机体血糖得到调节,提升血糖控制率,具备推广借鉴价值。

Objective Analyze the effect of long acting insulin combined with oral hypoglycemic agents for type 2 diabetes. Methods Select 100 cases of type 2 diabetic patients from January 2014 to January 2015 in the hospital. They were divided into study group and control group, 50 cases in each, the control group simply adopt hypoglycemic agents treatment, the study group took long-acting insulin therapy based on the control group, then compare their clinical effect. Results Study Group’s FBG （4.9±0.5）mmol/L, 2hpbg （7.9±2.1） mmol/L and HbA1c （5.9±1.0）%compared with the control group （8.1±0.9） mmol/L, （12.8±2.7） mmol/L and （8.7±1.6）% was significantly lower, comparative data exist significant difference （P〈0.05）; study group’s blood sugar control rate 94.0% compared with the control group 76.0% is significantly higher, the comparative data exist significant difference （P〈0.05）. Conclusion The effect of Long acting insulin combined with oral hypoglycemic agents for type 2 diabetes is ideal, which can obviously promote the patient blood glucose regulation, raise blood sugar control rate, with the promotion of reference value.